Patients should avoid self-sourcing CJC-1295 from online sellers because product purity, sterility, dose accuracy, and safety cannot always be verified
Other sGC stimulators and activators are currently in development for the treatment of CKD (NCT04507061, NCT04750577), with at least one study including participants with type 1 diabetes
Steven Shane, a pediatric obesity doctor out of Reno, told lawmakers on the Senate Committee on Health and Human Services last week that, although these types of medicinal and surgical treatments are expensive upfront, covering them would financially benefit the state in the long term by reducing the cost of chronic diseases associated with obesity
We would argue that the appropriate price would reflect the underlying value of the treatment
Prummel MF, Laurberg P
Tell patients to avoid exceeding the tolerable upper intake level (UL) of 350 mg daily